Results 101 to 110 of about 8,083 (126)

Anti-Vα24Jα18 TCR Antibody Tunes iNKT Cell Responses to Target and Kill CD1d-negative Tumors in an FcγRII (CD32)-dependent Manner. [PDF]

Cancer Res Commun
Takami M, Aoki T, Nishimura K, Tanaka H, Onodera A, Motohashi S.   +5 more
europepmc   +1 more source

Hippo/Mst signaling coordinates cellular quiescence with terminal maturation in iNKT cell development and fate decisions. [PDF]

J Exp Med, 2020
Raynor JL, Liu C, Dhungana Y, Guy C, Chapman NM, Shi H, Neale G, Sesaki H, Chi H.   +8 more
europepmc   +1 more source

The Role of Autophagy in iNKT Cell Development. [PDF]

Front Immunol, 2018
Yang G, Driver JP, Van Kaer L.
europepmc   +1 more source

The ins and outs of type I iNKT cell development. [PDF]

Mol Immunol, 2019
Shissler SC, Webb TJ.
europepmc   +1 more source

SLAM-ing the brakes on iNKT cell selection. [PDF]

Nat Immunol, 2019
Iyer SS, Huang YH, Blumberg RS.
europepmc   +1 more source

Enhancing the iNKT cell immunotherapy platform by combining optimised CAR endodomains with novel iNKT engagers

Ponnusamy K, Karaxhuku K, Jiang Y, Randzavola L, Ren H, Leontari I, Lye B, Zaidi M, Bartlett EJ, Tate EW, Pardalis V, Leonardos D, Nadafi R, Sarkar I, Reijmers RM, Bua M, Atta M, Katsarou A, Roberts IA, Chaidos A, Karadimitris A.   +20 more
europepmc   +1 more source

Alterations of the iNKT cell compartment in brain-injured patients. [PDF]

Crit Care, 2019
Patinec A, Rocher J, Vourc'h M, Roquilly A, Asehnoune K, Le Pendu J.   +5 more
europepmc   +1 more source

Systematic evaluation of MAIT and iNKT abundance as checkpoint blockade biomarkers. [PDF]

Front Immunol
Li Y, Chen L, Shan S, Wang H, Xing X, Zhang J.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy

Cell Reports Medicine, 2021
Lili Yang, Xi Wang, Matteo Pellegrini
exaly